Somatic Inactivation of the PHD2 Prolyl Hydroxylase Causes Polycythemia and Congestive Heart Failure

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2007 Dec 22

PMID 18096761

Citations 147

Authors

Yoji Andrew Minamishima

Javid Moslehi

Nabeel Bardeesy

Darragh Cullen

Roderick T Bronson

William G Kaelin Jr

Affiliations

Soon will be listed here.

Abstract

Pharmacologic activation of the heterodimeric HIF transcription factor appears promising as a strategy to treat diseases, such as anemia, myocardial infarction, and stroke, in which tissue hypoxia is a prominent feature. HIF accumulation is normally linked to oxygen availability because an oxygen-dependent posttranslational modification (prolyl hydroxylation) marks the HIFalpha subunit for polyubiquitination and destruction. Three enzymes (PHD1, PHD2, and PHD3) capable of catalyzing this reaction have been identified, although PHD2 (also called Egln1) appears to be the primary HIF prolyl hydroxylase in cell culture experiments. We found that conditional inactivation of PHD2 in mice is sufficient to activate a subset of HIF target genes, including erythropoietin, leading to striking increases in red blood cell production. Mice lacking PHD2 exhibit premature mortality associated with marked venous congestion and dilated cardiomyopathy. The latter is likely the result of hyperviscosity syndrome and volume overload, although a direct effect of chronic, high-level HIF stimulation on cardiac myocytes cannot be excluded.

Citing Articles

miR-210 overexpression increases pressure overload-induced cardiac fibrosis.

Zaccagnini G, Baci D, Tastsoglou S, Cozza I, Made A, Voellenkle C Noncoding RNA Res. 2025; 12:20-33.

PMID: 40034123 PMC: 11874870. DOI: 10.1016/j.ncrna.2025.01.009.

Postischemic inactivation of HIF prolyl hydroxylases in endothelium promotes maladaptive kidney repair by inducing glycolysis.

Tiwari R, Sharma R, Rajendran G, Borkowski G, An S, Schonfeld M J Clin Invest. 2024; 135(3).

PMID: 39621585 PMC: 11785929. DOI: 10.1172/JCI176207.

Targeting inflammation in perivascular cells and neuroimmune interactions for treating kidney disease.

Tanaka S Clin Exp Nephrol. 2024; 28(6):505-512.

PMID: 38630367 PMC: 11116252. DOI: 10.1007/s10157-024-02494-7.

PHD1-3 oxygen sensors in vivo-lessons learned from gene deletions.

Jucht A, Scholz C Pflugers Arch. 2024; 476(9):1307-1337.

PMID: 38509356 PMC: 11310289. DOI: 10.1007/s00424-024-02944-x.

Endothelial specific prolyl hydroxylase domain-containing protein 2 deficiency attenuates aging-related obesity and exercise intolerance.

Pan L, He X, Xu R, Bhattarai U, Niu Z, do Carmo J Geroscience. 2024; 46(4):3945-3956.

PMID: 38462569 PMC: 11226575. DOI: 10.1007/s11357-024-01108-0.

References

Mahon P, Hirota K, Semenza G . FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001; 15(20):2675-86. PMC: 312814. DOI: 10.1101/gad.924501. View

Schofield C, Ratcliffe P . Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol. 2004; 5(5):343-54. DOI: 10.1038/nrm1366. View

Hsieh M, Linde N, Wynter A, Metzger M, Wong C, Langsetmo I . HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques. Blood. 2007; 110(6):2140-7. PMC: 1976368. DOI: 10.1182/blood-2007-02-073254. View

Ivan M, Haberberger T, Gervasi D, Michelson K, Gunzler V, Kondo K . Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci U S A. 2002; 99(21):13459-64. PMC: 129695. DOI: 10.1073/pnas.192342099. View

Dayan F, Roux D, Brahimi-Horn M, Pouyssegur J, Mazure N . The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. Cancer Res. 2006; 66(7):3688-98. DOI: 10.1158/0008-5472.CAN-05-4564. View

Kido M, Du L, Sullivan C, Li X, Deutsch R, Jamieson S . Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J Am Coll Cardiol. 2005; 46(11):2116-24. DOI: 10.1016/j.jacc.2005.08.045. View

Ratan R, Siddiq A, Aminova L, Lange P, Langley B, Ayoub I . Translation of ischemic preconditioning to the patient: prolyl hydroxylase inhibition and hypoxia inducible factor-1 as novel targets for stroke therapy. Stroke. 2004; 35(11 Suppl 1):2687-9. DOI: 10.1161/01.STR.0000143216.85349.9e. View

Marxsen J, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T . Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J. 2004; 381(Pt 3):761-7. PMC: 1133886. DOI: 10.1042/BJ20040620. View

Heinrich A, Pelanda R, Klingmuller U . A mouse model for visualization and conditional mutations in the erythroid lineage. Blood. 2004; 104(3):659-66. DOI: 10.1182/blood-2003-05-1442. View

10.

Natarajan R, Salloum F, Fisher B, Kukreja R, Fowler 3rd A . Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ Res. 2005; 98(1):133-40. DOI: 10.1161/01.RES.0000197816.63513.27. View

11.

Gjoerup O, Chao H, DeCaprio J, Roberts T . pRB-dependent, J domain-independent function of simian virus 40 large T antigen in override of p53 growth suppression. J Virol. 2000; 74(2):864-74. PMC: 111607. DOI: 10.1128/jvi.74.2.864-874.2000. View

12.

Bernaudin M, Divoux D, MacKenzie E, Petit E, Schumann-Bard P . Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab. 2002; 22(4):393-403. DOI: 10.1097/00004647-200204000-00003. View

13.

Singh A, Szczech L, Tang K, Barnhart H, Sapp S, Wolfson M . Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006; 355(20):2085-98. DOI: 10.1056/NEJMoa065485. View

14.

Ma W, Tessarollo L, Hong S, Baba M, Southon E, Back T . Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene. Cancer Res. 2003; 63(17):5320-8. View

15.

RYAN H, Lo J, Johnson R . HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 1998; 17(11):3005-15. PMC: 1170640. DOI: 10.1093/emboj/17.11.3005. View

16.

Schmid R, GILBERSTSEN A . Fundamental observations on the production of compensatory polycythemia in a case of patent ductus arteriosus with reversed blood flow. Blood. 1955; 10(3):247-51. View

17.

Dooley T, Miranda M, Jones N, DePamphilis M . Transactivation of the adenovirus EIIa promoter in the absence of adenovirus E1A protein is restricted to mouse oocytes and preimplantation embryos. Development. 1989; 107(4):945-56. DOI: 10.1242/dev.107.4.945. View

18.

Aprelikova O, Chandramouli G, Wood M, Vasselli J, Riss J, Maranchie J . Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J Cell Biochem. 2004; 92(3):491-501. DOI: 10.1002/jcb.20067. View

19.

Bardeesy N, Sinha M, Hezel A, Signoretti S, Hathaway N, Sharpless N . Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature. 2002; 419(6903):162-7. DOI: 10.1038/nature01045. View

20.

Appelhoff R, Tian Y, Raval R, Turley H, Harris A, Pugh C . Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem. 2004; 279(37):38458-65. DOI: 10.1074/jbc.M406026200. View